SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Gillis S, Ferm MM, Ou W, Smith KA. T-cell growth factor: Parameters of production and quantitative microassay for activity. J Immunol 1978; 120: 20272035.
  • 2
    Brummer KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labeled allogeneic target cells in vitro; inhibition by antibody and by drugs. Immunology 1968; 14: 181189.
  • 3
    Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 5562.
  • 4
    Scudiero DA, Shoemaker RH, Paull KD, Monks A, Thierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. Evaluation of a soluble tetrasolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48: 48274833.
  • 5
    Marks DC, Belov L, Davey MW, Davey RA, Kidman AD. The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leuk Res 1992; 16: 11651173.
  • 6
    Shearman MS. Cellular MTT reduction distinguishes the mechanism of action of β-amyloid from that of tachykinin receptor peptides. Neuropeptides 1996; 30: 125132.
  • 7
    Bernas T, Dobrucki JW. The role of plasma membrane in bioreduction of two tetrazolium salts, MTT and CTC. Arch Biochem Biophys 2000; 380: 108116.
  • 8
    Bernas T, Dobrucki J. Mitochondrial and nonmitochondrial reduction of MTT: Interaction of MTT with TMRE, JC-1 and NAO mitochondrial fluorescent probes. Cytometry 2000; 47: 236242.
  • 9
    Cohen LS, Studzinski GP. Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis. J Cell Physiol 1967; 69: 331340.
  • 10
    Gong J. Traganos F, Darzynkiewicz Z. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth Differ 1995; 6: 14851493.
  • 11
    Kurose A, Tanaka T, Huang X, Traganos F, Darzynkiewicz Z. Synchronization in the cell cycle by inhibitors of DNA replication induces histone H2AX phosphorylation, an indication of DNA damage. Cell Prolif 2006; 39: 231240.
  • 12
    Wang Y-Y, Zheng XX. A flow cytometry-based assay for quantitative analysis of cellular proliferation and cytotoxicity in vitro. J Immunol Methods 2002; 268: 179188.
  • 13
    Pazos P, Fortaner S, Prieto P. Long-term in vitro toxicity models: Comparisons between a flow-cell bioreactor, a static-cell bioreactor and static cell cultures. Altern Lab Anim 2002; 30: 515523.
  • 14
    Ross DD, Joneckis CC, Ordonez JV, Sisk AM, Wu RK, Hamburger RE Nora AW, Nora RE. Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number. Cancer Res 1989; 49: 37763783.
  • 15
    Lee-MacAry AE, Ross EL, Davies D, Laylor R, Honeychurch J, Glennie MJ, Snary D, Wilkinson RW. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J Immunol Methods 2001; 252: 8392.
  • 16
    Darzynkiewicz Z, Li X, Gong JP. Assays of cell viability: Discrimination of cells dying by apoptosis. Methods Cell Biol 1994; 63: 1538.
  • 17
    Poot M, Silber JR, Rabinovitch PS. A novel flow cytometric technique for drug cytotoxicity gives results comparable to colony-forming assays. Cytometry 2002; 48: 15.
  • 18
    Darzynkiewicz Z, Bedner E, Traganos F. Difficulties and pitfalls in analysis of apoptosis. Methods Cell Biol 2001; 63: 527546.
  • 19
    Beske O, Guo J, Li J, Bassoni D, Bland K, Marciniak H, Zarowitz M, Temov V, Ravkin I, Goldbard S. A novel encoded particle technology that enables simultaneous interrogation of multiple cell types. J Biomol Screen 2004; 9: 173185.
  • 20
    Mandecki W, Pappas MG, Kogan N, Wang Z, Zamlynny B. Light-powered microtransponders for high multiplex-level analysis of nucleic acids. In: KordalR, UsmaniA, LawWT, editors. Microfabricated Sensors: Application of Optical Technology for DNA Analysis (ACS Symposium Series, Vol. 815). Washington, DC: American Chemical Society; 2002. pp 5769.
  • 21
    Mandecki W. Three-dimensional arrays of microtransponders derivatized with oligonucleotides. In Proceedings from the IBC Biochip Technologies Conference, San Francisco, June 1998. Southborough, MA: Drug & Market Development Publications; 1999. D&MD Library Series publication No. 1941, pp 179187.
  • 22
    Moran EJ, Sarshar S, Cargill JF, Shahbaz MM, Lio A, Mjalli AMM. Radio frequency tag encoded combinatorial library method for the discovery of tripeptide-substituted cinnamic acid inhibitors of the protein tyrosine phosphatase PTB1B. J Am Chem Soc 1995; 117: 10787, 10788.
  • 23
    Pappas MG, Wang Z, Zamlynny B, Mandecki W. Light-powered microchips for diagnostics, genomics and drug discovery. Lumin Forum 2000; 6: 4.
  • 24
    Braeckmans K, De Smedt SC, Leblans M, Roelant C, Pauwels R, Demeester J. Scanning the code for combichem. Mod Drug Discov February, 2003; 2832.
  • 25
    Kamentsky LA. Laser scanning cytometry. Methods Cell Biol 2001; 63: 5187.
  • 26
    Darzynkiewicz Z, Bedner E, Li X, Gorczyca W, Melamed MR. Laser scanning cytometry. A new instrumentation with many applications. Exp Cell Res 1999; 249: 112.
  • 27
    Pozarowski P, Huang X, Gong RW, Priebe W, Darzynkiewicz Z. Simple, semi-automatic assay of cytostatic and cytotoxic effects of antitumor drugs by laser-scanning cytometry (LSC): Effects of the bis-intercalator WP631 on growth and cell cycle of T-24 cells. Cytometry A 2004; 57: 113119.
  • 28
    Jakóbisiak M, Bruno S, Skierski J, Darzynkiewicz Z. The cell cycle specific effects of lovastatin. Proc Natl Acad Sci USA 1991; 88: 36283632.
  • 29
    Del Bino G, Skierski J, Darzynkiewicz Z. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 1991; 195: 485491.
  • 30
    Darzynkiewicz Z, Carter SP, Mikulski SM, Shogen K. Cytostatic and cytotoxic effects of Pannon, a novel anticancer agent. Cell Tissue Kinet 1988; 21: 169182.
  • 31
    Ardelt B, Ardelt W, Darzynkiewicz Z. Cytotoxic ribonucleases and RNA interference (RNAi). Cell Cycle 2003; 2: 2224.
  • 32
    Kapuscinski J, Darzynkiewicz Z. Relationship between the pharmacological activity of antitumor drugs Ametantrone and Mitoxantrone (Novatrone) and their ability to condense nucleic acids. Proc Natl Acad Sci USA 1986; 83: 63026306.
  • 33
    Smolewski P, Grabarek J, Kamentsky LA, Darzynkiewicz Z. Bivariate analysis of cellular DNA versus RNA content by laser scanning cytometry using the product of signal subtraction (differential fluorescence) as a separate parameter. Cytometry 2001; 45: 7378.
  • 34
    Traganos F, Darzynkiewicz Z, Melamed MR. The ratio of RNA to total nucleic acid content as a quantitative measure of unbalanced cell growth. Cytometry 1982; 2: 212218.